CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 10 enrolled
Drug / intervention
Deep Brain Stimulation for Thalamic Pain Syndromedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01072656
NCT01072656N/ACompleted

Deep Brain Stimulation for Thalamic Pain Syndrome

Andre Machado·interventional·Posted Feb 22, 2010·Updated Jun 9, 2017

In Brief

A clinical study evaluating Deep Brain Stimulation for Thalamic Pain Syndrome for Chronic Pain. Completed, enrolled 10 participants across 1 site.

Detailed Summary

The purpose of this study is to determine the safety and efficacy of Deep Brian Stimulation (DBS) of the ventral capsular/ventral striatal as a treatment for patients with Thalamic Pain Syndrome (TPS). The central hypothesis to be tested in this investigation is that VC/VS stimulation will modulate the affective component of TPS and, consequently, improve pain related disability.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Pain
CountriesUnited States

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 22, 2010
Enrollment StartMay 1, 2010
Primary CompletionAug 1, 2014
Study CompletionMar 1, 2016
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 16.4 years ago

Interventions

Deep Brain Stimulation for Thalamic Pain Syndromedevice

Patients will be randomized in a 1:1 ratio to one of two groups: the Treatment Group (active stimulation and programmed to the settings found to be optimal during the titration phase) and the Control Group (sham stimulation - IPG is set to ON but the voltage is set to 0V). In order to prevent too many patients from being randomized to ON or to sham early in the study, we will use, for the first 4 patients, randomization blocks of four or six. In this fashion, the first four consecutive patients will have two patients randomized to the Treatment Group and two patients in the Control Group. In the same fashion, the final six patients will have three patients randomized to the treatment group and three patients to the control group.